NPT-002

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNPT-002
Drug Alias NameNPT-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProclara Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProclara Biosciences Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A